Literature DB >> 10981005

The use and misuse of transjugular intrahepatic portasystemic shunts.

A J Sanyal1.   

Abstract

Transjugular intrahepatic portasystemic shunts, or TIPS, are used to create a low-resistance channel between the hepatic vein and the intrahepatic portion of the portal vein by deployment of an expandable metal stent. TIPS function like side-to-side surgical portacaval shunts, but their placement does not require anesthesia and major surgery. This article reviews the uses and misuses of TIPS in current practice. The uses include variceal hemorrhage and ascites as well as miscellaneous indications such as Budd-Chiari syndrome, veno-occlusive disease, bleeding ectopic and rectal varices, hepatic hydrothorax, and portal hypertensive gastropathy. TIPS is not indicated for primary prophylaxis of variceal hemorrhage, prehepatic portal hypertension, correction of hypersplenism and thrombocytopenia, pulmonary hypertension and hepatopulmonary syndrome, and portal hypertension associated with polycystic liver disease or Caroli's disease. Also reviewed herein is the management of patients after TIPS placement.

Entities:  

Mesh:

Year:  2000        PMID: 10981005     DOI: 10.1007/s11894-000-0053-5

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  91 in total

Review 1.  TIPS and hepatic encephalopathy.

Authors:  G Pomier-Layrargues
Journal:  Semin Liver Dis       Date:  1996-08       Impact factor: 6.115

2.  Transjugular intrahepatic portosystemic shunt for refractory ascites: shunt diameter-optimizing risks and benefits.

Authors:  K A Somberg
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

3.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.

Authors:  M Rössle; P Deibert; K Haag; A Ochs; M Olschewski; V Siegerstetter; K H Hauenstein; R Geiger; C Stiepak; W Keller; H E Blum
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

5.  The side-to-side portacaval shunt revisited.

Authors:  N D Grace
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

6.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

Review 7.  Refractory ascites.

Authors:  B A Runyon
Journal:  Semin Liver Dis       Date:  1993-11       Impact factor: 6.115

8.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

9.  Expandable venous stents for treatment of the Budd-Chiari syndrome.

Authors:  R R Lopez; K G Benner; L Hall; J Rösch; C W Pinson
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

10.  Ascites increases the resting energy expenditure in liver cirrhosis.

Authors:  C Dolz; J M Raurich; J Ibáñez; A Obrador; P Marsé; J Gayá
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  7 in total

Review 1.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02

2.  Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

3.  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  B Angermayr; M Cejna; F Karnel; M Gschwantler; F Koenig; J Pidlich; H Mendel; L Pichler; M Wichlas; A Kreil; M Schmid; A Ferlitsch; E Lipinski; H Brunner; J Lammer; P Ferenci; A Gangl; M Peck-Radosavljevic
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

4.  Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.

Authors:  Zai-Bo Jiang; Hong Shan; Xin-Ying Shen; Ming-Sheng Huang; Zheng-Ran Li; Kang-Shun Zhu; Shou-Hai Guan
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

5.  An emergency hybrid procedure that combines endoscopic treatment with partial splenic embolization for bleeding esophagogastric varices.

Authors:  Fumio Chikamori; Atsuki Maeda; Niranjan Sharma
Journal:  Radiol Case Rep       Date:  2022-03-19

6.  Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome.

Authors:  Hongwei Zhao; Fuquan Liu; Zhendong Yue; Lei Wang; Zhenhua Fan; Fuliang He
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 7.  Management of portal hypertension and ascites in polycystic liver disease.

Authors:  Lucas H P Bernts; Joost P H Drenth; Eric T T L Tjwa
Journal:  Liver Int       Date:  2019-09-20       Impact factor: 5.828

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.